Thiamine and benfotiamine improve cognition and ameliorate GSK-3β-associated stress-induced behaviours in mice.
Thiamine (vitamin B1) deficiency in the brain has been implicated in the development of dementia and symptoms of depression. Indirect evidence suggests that thiamine may contribute to these pathologies by controlling the activities of glycogen synthase kinase (GSK)-3β. While decreased G...
Prif Awduron: | Markova, N, Bazhenova, N, Anthony, D, Vignisse, J, Svistunov, A, Lesch, K, Bettendorff, L, Strekalova, T |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
Elsevier
2016
|
Eitemau Tebyg
-
Thiamine and benfotiamine prevent stress-induced suppression of hippocampal neurogenesis in mice exposed to predation without affecting brain thiamine diphosphate levels
gan: Vignisse, J, et al.
Cyhoeddwyd: (2017) -
Thiamine and benfotiamine: Focus on their therapeutic potential
gan: Iva Bozic, et al.
Cyhoeddwyd: (2023-11-01) -
Chemoreactomic analysis of thiamine disulfide, thiamine hydrochloride, and benfotiamine molecules
gan: O. A. Gromova, et al.
Cyhoeddwyd: (2017-07-01) -
Benfotiamine Supplementation Increases Thiamine in Muscle of Endurance-Trained Mice and Affects the Energy Metabolism
gan: Álisson C. Gonçalves, et al.
Cyhoeddwyd: (2024-01-01) -
Prostatic acid phosphatase is required for the antinociceptive effects of thiamine and benfotiamine.
gan: Julie K Hurt, et al.
Cyhoeddwyd: (2012-01-01)